Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.20 SEK | +3.19% |
|
+0.46% | -3.42% |
| 06-10 | RaySearch Head of Business Development Jenna Styan makes maiden share purchase | FW |
| 06-05 | RaySearch to showcase new particle therapy solutions at PTCOG 64 | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 7,316 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -6.4% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 7,226 | 7,051 | 6,818 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -7.41% | -2.42% | -3.3% |
| P/E Ratio | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 25.6x | 20.6x | 17.1x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 6.45x | 5.42x | 4.57x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1x | 0.8x | 0.9x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 5.19x | 4.56x | 4.08x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 5.13x | 4.4x | 3.8x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 11x | 9.25x | 7.87x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 19.5x | 15.4x | 12.4x |
| EV / FCF | 234x | - | - | - | 21.7x | 38.2x | 24.1x | 17.7x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.62% | 4.16% | 5.66% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 5.18 | 6.23 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 1.87% | 2.43% | 2.92% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 8.32 | 10.37 | 12.45 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 48.1% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,409 | 1,603 | 1,795 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 655 | 762 | 866 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 370 | 459 | 549 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 285 | 355 | 426 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | -90 | -265 | -498 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 213.40 | 213.40 | 213.40 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.65x | 5.13x | 11.03x | 1.87% | 767M | |
| 25.26x | 5.22x | 11.56x | -.--% | 26.24B | |
| 70.69x | 64.26x | 75.24x | 0.51% | 11.9B | |
| 102.91x | 16.27x | 69.98x | 0.63% | 6.1B | |
| -40.89x | 10.93x | -58.6x | - | 2.65B | |
| 48.49x | - | - | -.--% | 1.72B | |
| -5.65x | 55.47x | -5.62x | - | 1.66B | |
| -134.63x | - | - | - | 1.26B | |
| -117.67x | - | - | 1.13% | 807M | |
| Average | -2.87x | 26.21x | 17.27x | 0.69% | 5.9B | |
| Weighted average by Cap. | 34.89x | 22.83x | 29.80x | 0.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
